Healthequity (NASDAQ:HQY) had its price objective raised by equities research analysts at KeyCorp from $90.00 to $105.00 in a report issued on Tuesday, MarketBeat Ratings reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s price target indicates a potential upside of 11.15% from the stock’s previous close.

A number of other research firms also recently weighed in on HQY. Zacks Investment Research raised Healthequity from a “sell” rating to a “hold” rating in a research report on Friday, July 20th. Cantor Fitzgerald downgraded Healthequity from an “overweight” rating to a “neutral” rating and set a $65.00 target price on the stock. in a research report on Wednesday, May 30th. Barrington Research lifted their target price on Healthequity to $85.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 5th. They noted that the move was a valuation call. Oppenheimer lifted their target price on Healthequity from $68.00 to $85.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 5th. Finally, Robert W. Baird lifted their target price on Healthequity from $61.00 to $77.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 5th. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $82.91.

HQY stock opened at $94.47 on Tuesday. Healthequity has a twelve month low of $41.28 and a twelve month high of $96.29. The stock has a market cap of $5.85 billion, a P/E ratio of 174.94, a PEG ratio of 3.92 and a beta of 1.46.

Healthequity (NASDAQ:HQY) last released its earnings results on Tuesday, September 4th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $0.12. Healthequity had a return on equity of 13.47% and a net margin of 22.91%. The business had revenue of $71.10 million for the quarter, compared to the consensus estimate of $69.84 million. During the same period last year, the business earned $0.27 earnings per share. The firm’s revenue for the quarter was up 25.0% compared to the same quarter last year. analysts anticipate that Healthequity will post 0.72 EPS for the current year.

In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction on Monday, August 20th. The shares were sold at an average price of $86.37, for a total transaction of $345,480.00. Following the completion of the sale, the vice president now owns 99,200 shares in the company, valued at approximately $8,567,904. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Gary D. Robinson sold 2,100 shares of the company’s stock in a transaction on Thursday, June 7th. The shares were sold at an average price of $80.49, for a total transaction of $169,029.00. Following the sale, the executive vice president now owns 4,990 shares of the company’s stock, valued at approximately $401,645.10. The disclosure for this sale can be found here. Insiders sold 51,600 shares of company stock valued at $4,101,110 in the last quarter. 4.00% of the stock is currently owned by corporate insiders.

Several hedge funds have recently made changes to their positions in the company. Hilltop Holdings Inc. grew its holdings in shares of Healthequity by 16.8% in the 2nd quarter. Hilltop Holdings Inc. now owns 4,868 shares of the company’s stock valued at $366,000 after buying an additional 700 shares during the period. Riverhead Capital Management LLC grew its holdings in shares of Healthequity by 3.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 18,829 shares of the company’s stock valued at $1,414,000 after buying an additional 713 shares during the period. Advisors Asset Management Inc. boosted its stake in Healthequity by 57.4% in the 2nd quarter. Advisors Asset Management Inc. now owns 2,136 shares of the company’s stock worth $160,000 after purchasing an additional 779 shares during the period. New York State Teachers Retirement System boosted its stake in Healthequity by 2.5% in the 2nd quarter. New York State Teachers Retirement System now owns 34,957 shares of the company’s stock worth $2,625,000 after purchasing an additional 841 shares during the period. Finally, Mason Street Advisors LLC boosted its stake in Healthequity by 7.0% in the 1st quarter. Mason Street Advisors LLC now owns 14,307 shares of the company’s stock worth $866,000 after purchasing an additional 934 shares during the period. 96.99% of the stock is owned by institutional investors.

About Healthequity

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: Price to Earnings Ratio (PE)

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.